The Nifty opened at 15064.40 with a big gap up of 145 points. The index initially moved down a little bit and recorded its intraday low at 14995.80. After that prices have rallied throughout the day. A rally of more than 250 points helped the index to close at 15245.60 with a gain of 326.50 points. All sectoral indices have closed with gains except the Auto. The Metal, Bank and Financial have led the bulls and closed with a gain of more than 2.50%.
We had suggested a long trade. The trade was to buy above 14950. But if the index opens with a gap up above 14950 then we should buy above the first 15 minutes high. Nifty opened well above 14950 and recorded the first 15 minutes of high around 15065. Prices broke that high around 10:30 AM so we took a long trade there. We have suggested a target of 15200. A strong intraday rally helped prices to reach the target. So our long position closed with a gain of 135 points. It was a trend day in the index on the upside where the opening tick was near the intraday low and closing tick near the intraday high. Rally continued for the third day in the Nifty with more strong momentum in the prices. Prices are now heading towards its lifetime high. Today is the weekly expiry and we could see some choppy action.
Bank Nifty opened at 35754.55 with a gap up of 281 points. For the first 30 minutes of trading, the index moved sideways. After that prices have seen one way of journey on the upside & finally closed at 36368. PSU & Private Banks both have performed well and closed higher by more than 2% of gains. Within the index,in terms of points ICICI Bank contributed highest followed by Axis Bank. We had suggested a long trade. The trade was to buy above 35750 or high of first 15 minutes. The index crossed its high of 35850 immediately. Prices neither touched the stop nor the target. But are trading very close to the target of 36500. Book profits in the morning.
Trade AnyTime AnyWhere With Elite Empower Mobile App
|GRANLUES||364.40||BUY||The stock has given a breakout from a narrow trading range. The stock can be bought between 358-360 with a stop at 352 and for the target 377|
|BANDHAN BANK||354.90||BUY||The stock has given a breakout from a narrow trading range. The stock can be bought at CMP with a stop at 347 and for the target 370|
Get All Your Mutual Fund Portfolio Returns on Your Mobile by Elite Kuber App
|STOCK OPTION||Strike Price||Buy/Sell||CMP||Initiation||Stop Loss||Target||Remarks|
|Long Buildup||Short Buildup|
|Stocks||Price||Price%||OI %||OI||Stocks||Price||Price%||OI %||OI|
|CUB.21.03 Mar||183.3||3.68||188.96||6575100||LTTS.21.03 Mar||2722.6||-0.97||69.32||199800|
|NAM-INDIA.21.03 Mar||366.85||5.43||122.83||1640000||MPHASIS.21.03 Mar||1699||-0.37||48.83||144625|
|GRANULES.21.03 Mar||370.4||9.42||86.47||4271800||ALKEM.21.03 Mar||2864.95||-2.44||43.41||119600|
|FINNIFTYW.21.03 Mar||16890.5||2.94||63.85||8520||APLLTD.21.03 Mar||934.1||-0.8||28.76||216700|
|AUBANK.21.03 Mar||1223.85||5.36||49||298000||PFIZER.21.03 Mar||4680.1||-0.18||15||31625|
|Short Covering||Long Unwinding|
|Stocks||Price||Price%||OI%||OI||Stocks||Price||Price %||OI %||OI|
|TRENT.21.03 Mar||915||0.34||-7.07||342925||SAIL.21.03 Mar||79||-0.32||-5.44||133304000|
|DIVISLAB.21.03 Mar||3571.65||1.24||-2.64||3059800||PAGEIND.21.03 Mar||29399.95||-0.47||-2.81||72690|
|ESCORTS.21.03 Mar||1347.2||2.09||-1.83||2809950||IRCTC.21.03 Mar||1903.65||-0.33||-0.74||1268150|
Top Delivery Percentage
|Stocks||Price||%Chg||Total Qty||Delivery||Del %||% Change|
|Hindustan Unilever Ltd||2193.5||0.71||2031893||1336750||63.8||Nifty Metal||4058.6||3.34||81600|
|Infosys Limited||1343.55||2.99||9056399||6551888||62.63||Nifty Bank||36368.05||2.68||81600|
|Icici Lombard General In||1496.9||4.59||576058||286501||62.53||Nifty 50||15245.6||2.19||81600|
|Britannia Ind Ltd.||3481.15||0.96||409493||234884||61.17||Nifty Energy||19670.05||1.9||81600|
|Torrent Pharma Ltd.||2497.35||1.1||401553||277696||61.06||Nifty it||25772.65||1.86||81600|
|Kotak Mahindra Bank Limi||1899.5||2.97||2875618||2253657||58.73||Nifty Realty||362.45||1.5||81600|
|Alembic Pharmaceuticals||929.65||-0.6||452319||155582||57.39||Nifty Pharma||12379.6||1||81600|
|Hdfc Ltd.||2654.9||3.55||5640063||2300989||56.31||Nifty Media||1719.75||0.63||81600|
|Max Financial Services l||923.95||3.47||2547802||1334376||55.45||Nifty Fmcg||33454.4||0.61||81600|
Upcoming Economic Data
|INR: FX Reserves, USD on 5th March, 2021||•USD : Initial Jobless Claims on 4th March, 2021
•USD : Nonfarm Payrolls (Feb) on 5th March, 2021
Get Stock Market Recommendation By Our Research Analysts
|•As pent-up demand is pushing up volumes, Berger Paints, country’s second largest paints maker in the decorative segment, , is aiming to accelerate and expand its manufacturing capacity. Berger is in the process of setting up a Rs 700-crore plant in Uttar Pradesh and the commissioning of the plant is now being brought forward on account of high capacity utilization at its existing facilities.
•Mumbai-based drug major Cipla said its Gulf subsidiary is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand that had an aggregate sales of $700 mn in 2020 in Australia.
•Tata Motors is all set to challenge Tesla before the latter begins manufacturing in India. The company’s Jaguar Land Rover India on Wednesday said it has set up charging infrastructure across 22 retail outlets in the country as it prepares to launch its all-electric SUV, Jaguar I-PACE, later this month.
•Easy Trip Planners Pvt., the holding company for online travel portal easemytrip.com, will sell shares at Rs 186-187 apiece through an initial public offering next week. The company will launch its Rs 510-crore maiden float on March 8, according to its red herring prospectus. It comprises an offer-for-sale of 2.72 crore shares, amounting to 25.10% of the paid-up equity. At the upper end of the price band, Easy Trip will be valued at Rs 2,031 crore.
Source: Economic Times, Moneycontrol ,Business Today, Livemint, Business Standard, Bloomberg Quint
|Company Name||Purpose||Ex-Date||Company Name||Purpose||Ex-Date|
|JAYSHREETEA||General;Scheme of Arrangement||04-Mar-21||COALINDIA||Interim Dividend||05-Mar-21|
|KLBRENG-B||Preferential Issue of shares||04-Mar-21||ICICIGI||Interim Dividend||05-Mar-21|
|RCRL||Half Yearly Results||04-Mar-21||MSRINDIA||General||05-Mar-21|
|WARDINMOBI||General||04-Mar-21||SCTL||Scheme of Arrangement||05-Mar-21|
|Company Name||Ex-Date||Purpose||Company Name||Ex-Date||Purpose|
|BHARATRAS||04-Mar-21||Buy Back of Shares||SELMCL||09-Mar-21||Resolution Plan -Suspension|
|RAJPALAYAM||04-Mar-21||Right Issue of Equity Shares||THANGAMAYL||09-Mar-21||Interim Dividend – Rs. – 6.00|
|SOTL||04-Mar-21||Buy Back of Shares||TRIOMERC||09-Mar-21||Bonus issue 1:6|
|HAL||05-Mar-21||Interim Dividend – Rs. – 15.00||TRIOMERC||09-Mar-21||Stock Split From Rs.10/- to Rs.2/-|
|RPIL||05-Mar-21||E.G.M.||DICIND||10-Mar-21||Final Dividend – Rs. – 6.00|
|POWERGRID||08-Mar-21||Interim Dividend – Rs. – 4.00||KIRLFER||10-Mar-21||Interim Dividend – Rs. – 2.00|
|SACHEMT||08-Mar-21||Bonus issue 1:10||MARICO||10-Mar-21||Interim Dividend|
|KEI||09-Mar-21||Interim Dividend – Rs. – 2.00||COALINDIA||15-Mar-21||Interim Dividend|
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, email@example.com
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.Company-Specific Disclosures Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in , or e-mailing firstname.lastname@example.org with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail email@example.com.Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person. Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company in the analyst’s area of coverage. Country Specific Disclosures India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking
or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL Advisory
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL Advisory or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL Advisory has never been engaged in market making activity for the subject company;
(6) EWL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.